Tatiana López del Río

Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge.

Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge.

Nanogap Sub NM Powder SA provides research and development of nanotechnology materials. It serves in the medical, electronic and packaging industries. The firm offers atomic quantum clusters and nanoparticle dispersions in a variety of carrier liquids and solutions. The company was founded by Jose Rivas, Tatiana Lopez del Rio, Vazquez Carlos Vazquez and Arturo Lopez Quintelas in 2006 and is headquartered in Ames, Spain.

Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge.

Nanogap Sub NM Powder SA provides research and development of nanotechnology materials. It serves in the medical, electronic and packaging industries. The firm offers atomic quantum clusters and nanoparticle dispersions in a variety of carrier liquids and solutions. The company was founded by Jose Rivas, Tatiana Lopez del Rio, Vazquez Carlos Vazquez and Arturo Lopez Quintelas in 2006 and is headquartered in Ames, Spain.